RISA Labs, co-founded by IIT Kanpur graduates Kshitij Jaggi and Kumar Shivang, has raised $3.5 million in seed funding to tackle life-threatening delays in cancer treatment caused by administrative bottlenecks. The round saw participation from prominent investors, including a Flipkart co-founder and global venture capital firms.
The Hidden Crisis in Cancer Care
For cancer patients, delays in treatment approval can be deadly. Manual prior authorization processes—often riddled with paperwork and inefficiencies—force 70% of patients to wait weeks for care. In one-third of cases, delays stretch to a month, increasing mortality risks by 13% for aggressive cancers.
BOSS Platform: Cutting Wait Times by 85%
RISA’s flagship solution, BOSS (Business Operating System as a Service), streamlines administrative workflows using AI-driven automation. The platform breaks complex tasks into micro-jobs handled by a digital workforce, including language models and reinforcement learning agents. At a US cancer center, BOSS slashed prior authorization time from 30 minutes to under five, processed $1 million in medications, and freed 80% of staff hours, reducing costs by 66%.
Scaling RISA Labs for Impact
The funding will help deploy BOSS across 100 cancer centers in the US within two years. The startup aims to expand its AI orchestration layer to connect providers, drugmakers, and care platforms, ensuring seamless coordination across the cancer care ecosystem.
Founders’ Journey: From Frustration to Innovation
Jaggi and Shivang, who previously built Urban Health, launched RISA Labs after encountering fragmented healthcare workflows firsthand. Their research on digital twins in oncology operations laid the groundwork for BOSS, which embeds AI directly into hospital systems to boost efficiency. With strong investor backing, RISA Labs exemplifies how Indian expertise can solve global healthcare challenges. By eliminating administrative roadblocks, the startup ensures doctors focus on patients, not paperwork, saving lives one workflow at a time.